Literature DB >> 24449060

The MoSt Project--more steps in multiple sclerosis: a Delphi method consensus initiative for the evaluation of mobility management of MS patients in Italy.

Ruggero Capra1, Mario Alberto Battaglia, Antonio Gaudioso, Laura Lopes, Damiano Paolicelli, Marco Paoloni, Carlo Pozzilli, Valter Santilli, Claudio Solaro, Maria Trojano.   

Abstract

The aim of the study was to identify the main factors that impact mobility impairment in multiple sclerosis (MS) patients in Italy. Clinicians from a large number of Italian MS centers took part in a Delphi process aimed at obtaining consensus statements among the participants. Large consensus was obtained for statements grouped under the following main MS themes: identification of the most useful scales to evaluate mobility, integration of objective evaluation with patient perceptions, impact of walking impairment on daily life, management of the disabled patient using a rehabilitative and pharmacological approach. The consensus statements developed by a large number of experts may be used as a practical reference tool to help physicians treat MS patients with motor impairment.

Entities:  

Mesh:

Year:  2014        PMID: 24449060     DOI: 10.1007/s00415-013-7230-6

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  15 in total

1.  Delphi as a method to establish consensus for diagnostic criteria.

Authors:  Brent Graham; Glenn Regehr; James G Wright
Journal:  J Clin Epidemiol       Date:  2003-12       Impact factor: 6.437

Review 2.  Assessing walking disability in multiple sclerosis.

Authors:  Bernd C Kieseier; Carlo Pozzilli
Journal:  Mult Scler       Date:  2012-04-24       Impact factor: 6.312

3.  The relationship between walking, manual dexterity, cognition and activity/participation in persons with multiple sclerosis.

Authors:  Marie Kierkegaard; Ulrika Einarsson; Kristina Gottberg; Lena von Koch; Lotta Widén Holmqvist
Journal:  Mult Scler       Date:  2011-10-07       Impact factor: 6.312

4.  Day-to-day variability of maximum walking distance in MS patients can mislead to relevant changes in the Expanded Disability Status Scale (EDSS): average walking speed is a more constant parameter.

Authors:  H Albrecht; C Wötzel; L P Erasmus; M Kleinpeter; N König; W Pöllmann
Journal:  Mult Scler       Date:  2001-04       Impact factor: 6.312

5.  Approaches to the management of agents used for the treatment of multiple sclerosis: consensus statements from a panel of U.S. managed care pharmacists and physicians.

Authors:  Ross M Miller; Laura E Happe; Kellie L Meyer; Rachel J Spear
Journal:  J Manag Care Pharm       Date:  2012 Jan-Feb

6.  Costs and quality of life of multiple sclerosis in Italy.

Authors:  Gisela Kobelt; Jenny Berg; Peter Lindgren; M Battaglia; C Lucioni; A Uccelli
Journal:  Eur J Health Econ       Date:  2006-09

7.  Clinical impact of 20% worsening on Timed 25-foot Walk and 9-hole Peg Test in multiple sclerosis.

Authors:  J J Kragt; F A H van der Linden; J M Nielsen; B M J Uitdehaag; C H Polman
Journal:  Mult Scler       Date:  2006-10       Impact factor: 6.312

8.  Walking speed, rather than Expanded Disability Status Scale, relates to long-term patient-reported impact in progressive MS.

Authors:  Lvae Bosma; J J Kragt; C H Polman; B M J Uitdehaag
Journal:  Mult Scler       Date:  2012-08-20       Impact factor: 6.312

9.  Impact of mobility impairment on indirect costs and health-related quality of life in multiple sclerosis.

Authors:  Craig I Coleman; Matthew F Sidovar; Matthew S Roberts; Christine Kohn
Journal:  PLoS One       Date:  2013-01-23       Impact factor: 3.240

10.  Social and economic burden of walking and mobility problems in multiple sclerosis.

Authors:  James Pike; Edward Jones; Krithika Rajagopalan; James Piercy; Peter Anderson
Journal:  BMC Neurol       Date:  2012-09-18       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.